Share information
254.00 €
-3.75 %
20/04/2026 15:53
-3.75 %
Open
High
Low
Volume
261.50 €
261.50 €
253.80 €
58,827
Latest News
17-Apr-2026
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
17-Apr-2026
Acquisition of own shares
15-Apr-2026
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
10-Apr-2026
Acquisition of own shares